subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Childhood Medulloblastoma


subject: PUBCHEM.COMPOUND:58641927

subject_name: Ulixertinib

object_name: Refractory Rhabdomyosarcoma

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:58641927

object_name: Hepatoblastoma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Ewing Sarcoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Medulloblastoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Neuroblastoma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Hepatoblastoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Osteosarcoma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Neuroblastoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Osteosarcoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Ependymoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Glioma


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Glioma


subject: UMLS:C4287812

subject_name: ulixertinib

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C4287812

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4287812

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C4287812

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C4287812

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4287812

object_name: Recurrent Histiocytic and Dendritic Cell Neoplasm


subject: UMLS:C4287812

object_name: Refractory Histiocytic and Dendritic Cell Neoplasm


subject: UMLS:C4287812

object_name: nephroblastoma


subject: UMLS:C4287812

object_name: Wilms tumor


subject: UMLS:C4287812

object_name: childhood kidney Wilms tumor


subject: UMLS:C4287812

object_name: Recurrent Langerhans Cell Histiocytosis


subject: UMLS:C4287812

object_name: Refractory Langerhans Cell Histiocytosis


subject: UMLS:C4287812

object_name: Recurrent Malignant Germ Cell Tumor


subject: UMLS:C4287812

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: UMLS:C4287812

object_name: Recurrent Rhabdoid Tumor


subject: UMLS:C4287812

object_name: Refractory Childhood Malignant Germ Cell Tumor


subject: UMLS:C4287812

object_name: Refractory Malignant Germ Cell Tumor


subject: UMLS:C4287812

object_name: Refractory Rhabdoid Tumor


subject: UMLS:C4287812

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C4287812

object_name: Recurrent Peripheral Primitive Neuroectodermal Tumor


subject: UMLS:C4287812

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C4287812

object_name: Refractory Peripheral Primitive Neuroectodermal Tumor


subject: UMLS:C4287812

object_name: Recurrent Primary Malignant Central Nervous System Neoplasm


subject: UMLS:C4287812

object_name: Refractory Primary Malignant Central Nervous System Neoplasm


subject: UMLS:C4287812

object_name: Recurrent Ependymal Tumor


subject: UMLS:C4287812

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: UMLS:C4287812

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C4287812

object_name: Recurrent Soft Tissue Sarcoma


subject: UMLS:C4287812

object_name: Refractory Soft Tissue Sarcoma


subject: UMLS:C4287812

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: UMLS:C4287812

object_name: Recurrent Rhabdomyosarcoma


subject: UMLS:C4287812

object_name: Ewing's sarcoma recurrent


subject: UMLS:C4287812

object_name: Recurrent Medulloblastoma


subject: UMLS:C4287812

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C4287812

object_name: Refractory Rhabdomyosarcoma


subject: UMLS:C4287812

object_name: Hepatoblastoma recurrent


subject: UMLS:C4287812

object_name: Refractory Ewing Sarcoma


subject: UMLS:C4287812

object_name: Refractory Medulloblastoma


subject: UMLS:C4287812

object_name: Neuroblastoma recurrent


subject: UMLS:C4287812

object_name: Refractory Hepatoblastoma


subject: UMLS:C4287812

object_name: Osteosarcoma recurrent


subject: UMLS:C4287812

object_name: Refractory Neuroblastoma


subject: UMLS:C4287812

object_name: Refractory Osteosarcoma


subject: UMLS:C4287812

object_name: Refractory Ependymoma


subject: UMLS:C4287812

object_name: Recurrent Glioma


subject: UMLS:C4287812

object_name: Refractory Glioma


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: gastric adenocarcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UMLS:C4733585

subject_name: allogeneic cell immunotherapy ACIT-1

object_name: cancer

tested_intervention: yes


subject: UMLS:C4733585

object_name: neoplasm


subject: UMLS:C5206857

subject_name: 5-HT4 Agonist TAK-954

object_name: Gastroparesis due to diabetes mellitus


subject: UMLS:C5206857

object_name: idiopathic gastroparesis


subject: UMLS:C5690382


subject: UMLS:C2742210

object_name: triple-negative breast carcinoma


subject: UMLS:C2742210

object_name: Progesterone Receptor Negative


subject: UMLS:C2742210

object_name: Estrogen Receptor Negative


subject: UMLS:C2742210

object_name: HER2/Neu Negative


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:66903

object_name: Carcinoma breast stage IV


subject: CHEBI:66903

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:66903

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:66903

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:66903

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:66903

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:66903

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:66903

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:66903

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:66903

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:66903

object_name: Breast cancer recurrent


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:66903


subject: CHEBI:232553

object_name: cancer


subject: CHEBI:232553

object_name: neoplasm


subject: DRUGBANK:DB04976


subject: DRUGBANK:DB04976


subject: CHEBI:135145

subject_name: Neridronic Acid

object_name: complex regional pain syndrome type 1


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: Platinum-Resistant Disease


subject: UMLS:C3640818


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: lupus nephritis


subject: UMLS:C0042210

subject_name: Vaccines

object_name: AIDS


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:50853

subject_name: quantum dot

object_name: atopic eczema


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:4672

object_name: Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: pulmonary hypertension


subject: CHEBI:76004

object_name: systemic sclerosis


subject: CHEBI:17741

subject_name: N,N-dimethylformamide


subject: CHEBI:17741


subject: PUBCHEM.COMPOUND:66660570

subject_name: Evogliptin

object_name: type 2 diabetes mellitus


subject: CHEBI:33390

subject_name: curium atom

object_name: alcohol abuse


subject: CHEBI:33390

object_name: alcohol dependence


subject: CHEBI:76018

subject_name: Riociguat

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:8772

subject_name: Raloxifene

object_name: benign prostatic hyperplasia


subject: CHEBI:10127

subject_name: Zonisamide

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:91826710

subject_name: dolcanatide

object_name: colorectal carcinoma


subject: UNII:WU977T914K

subject_name: Dolcanatide


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: Cannabis use disorder


subject: CHEBI:13719

subject_name: acetylsalicylate

object_name: Aspirin asthma


subject: CHEBI:13719

object_name: Aspirin-induced asthma


subject: CHEBI:13719

object_name: asthma, nasal polyps, and aspirin intolerance


subject: CHEBI:13719

object_name: ASA intolerant asthma


subject: UMLS:C0304348

subject_name: acetyl salicylate


subject: UMLS:C0304348


subject: UMLS:C0304348


subject: UMLS:C0304348


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: CHEBI:135207


subject: CHEBI:135207


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: UMLS:C4329332

subject_name: Fianlimab

object_name: cancer


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: non-small cell lung carcinoma


subject: UMLS:C3658854


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Psychological Distress


subject: CHEBI:3756

subject_name: Clonazepam


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: anthrax disease


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: chronic kidney disease


subject: UNII:9U7D5QH5AE


subject: CHEBI:8382

subject_name: Prednisone

object_name: erythema multiforme


subject: CHEBI:8382

object_name: Erythema Multiforme, CTCAE


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Prostate cancer recurrent


subject: UMLS:C2346820


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Recurrent Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:72317

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:53477758

object_name: autism


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:114785

subject_name: Erlotinib

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:114785

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Adult Solid Neoplasm


subject: CHEBI:18305

subject_name: Arbutin

object_name: Melasma


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: adult hepatocellular carcinoma


subject: UNII:68AYS9A614

object_name: liver carcinoma


subject: UNII:68AYS9A614

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UNII:68AYS9A614

object_name: advanced adult primary liver cancer


subject: UNII:68AYS9A614

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Neoplasm, Residual


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:52172

subject_name: Nilotinib


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Low Grade Adult Non-Hodgkin's Lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: plasma cell myeloma


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: perianal Crohn disease


subject: UNII:089658A12D

object_name: Fistulising Crohn's disease


subject: UMLS:C5222466

subject_name: Methoxsalen Injection

object_name: Sezary syndrome


subject: UNII:97I1C92E55

subject_name: CEFIXIME

object_name: Childhood Solid Neoplasm


subject: UNII:97I1C92E55


subject: UNII:97I1C92E55

object_name: Solid Neoplasm


subject: CHEBI:472657

subject_name: Cefixime


subject: CHEBI:472657


subject: CHEBI:472657


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: influenza


subject: CHEBI:22652

object_name: common cold


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: UMLS:C1831860

subject_name: Beneo Synergy 1

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1831860

object_name: obesity


subject: UMLS:C1831860

object_name: Obesity, CTCAE


subject: UMLS:C5554951

subject_name: Bcl-2 Inhibitor ZN-d5


subject: UMLS:C5554951

object_name: AL amyloidosis


subject: UMLS:C5554951

object_name: amyloidosis


subject: CHEBI:567361

subject_name: Cladribine

object_name: leukemia


subject: CHEBI:567361

object_name: childhood leukemia


subject: CHEBI:87681

subject_name: Ranolazine

object_name: long QT syndrome


subject: CHEBI:87681

object_name: familial long QT syndrome


subject: CHEBI:87681

object_name: Prolonged QT interval


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: Immunosuppression


subject: PUBCHEM.COMPOUND:135582802

object_name: Decreased Immunologic Activity [PE]


subject: PUBCHEM.COMPOUND:135582802

object_name: liver failure


subject: PUBCHEM.COMPOUND:135582802

object_name: kidney failure


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:151315

subject_name: Heparin

object_name: congenital arteriovenous fistula


subject: CHEBI:151315

object_name: Arteriovenous fistula only (in use with two needles)


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Metastatic malignant neoplasm to liver


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:91353

object_name: non-small cell lung carcinoma


subject: CHEBI:91353

object_name: pancreatic neoplasm


subject: CHEBI:91353

object_name: colorectal neoplasm


subject: CHEBI:91353

object_name: breast neoplasm


subject: UNII:581F7DFA9B

subject_name: Olorinab

object_name: Abdominal pain


subject: UNII:581F7DFA9B

object_name: Abdominal Pain, CTCAE


subject: UNII:581F7DFA9B

object_name: Crohn disease


subject: CHEBI:59173

subject_name: Bivalirudin

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UNII:03J11K103C

subject_name: ALGELDRATE

object_name: staphylococcal toxic-shock syndrome


subject: UMLS:C5854547

subject_name: RIP1 Inhibitor GDC-8264

object_name: acute kidney failure


subject: UMLS:C5854547

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:40279

subject_name: Allopurinol

object_name: coronary microvascular disorder


subject: CHEBI:8426

subject_name: Probenecid

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:122660464

subject_name: rongliflozin


subject: CHEBI:49807

object_name: Acquired Nephrogenic Diabetes Insipidus


subject: CHEBI:49807

object_name: nephrogenic diabetes insipidus


subject: CHEBI:49807

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:49807

object_name: Congenital Nephrogenic Diabetes Insipidus


subject: CHEBI:25016

subject_name: lead atom


subject: CHEBI:25016


subject: CHEBI:25016


subject: CHEBI:25016


subject: CHEBI:53319

subject_name: polybutadiene macromolecule


subject: CHEBI:53319


subject: CHEBI:53319


subject: CHEBI:53319


subject: CHEBI:60686

subject_name: polybutadiene polymer


subject: CHEBI:60686


subject: CHEBI:60686


subject: CHEBI:60686


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: adult acute myeloid leukemia


subject: CHEBI:63977


subject: CHEBI:71019

subject_name: omacetaxine


subject: UMLS:C4525955

subject_name: Anti-CTLA4 Monoclonal Antibody BMS-986218

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4525955

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4525955

object_name: Metastatic liver carcinoma


subject: UMLS:C4525955

object_name: Metastatic Lung Carcinoma


subject: UMLS:C4525955

object_name: Stage IIIB Adult Liver Cancer AJCC v7


subject: UMLS:C4525955

object_name: Stage IIIC Adult Liver Cancer AJCC v7


subject: UMLS:C4525955

object_name: Stage III Liver Cancer


subject: UMLS:C4525955

object_name: Stage IIIA Adult Liver Cancer AJCC v7


subject: UMLS:C4525955

object_name: Stage III Adult Liver Cancer AJCC v7


subject: UMLS:C4525955

object_name: Stage IV Liver Cancer


subject: UMLS:C4525955

object_name: Stage IV Adult Liver Cancer AJCC v7


subject: UMLS:C4525955

object_name: Hepatic cancer stage IVA


subject: UMLS:C4525955

object_name: Stage IVB Liver Cancer


subject: UMLS:C4525955

object_name: Advanced Lung Carcinoma


subject: UMLS:C4525955

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C4525955

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C4525955

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C4525955

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C4525955

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C4525955

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C4525955

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C4525955

object_name: Adrenal Cancer


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic liver carcinoma


subject: CHEBI:231614

object_name: Metastatic Lung Carcinoma


subject: CHEBI:231614

object_name: Stage IIIB Adult Liver Cancer AJCC v7


subject: CHEBI:231614

object_name: Stage IIIC Adult Liver Cancer AJCC v7


subject: CHEBI:231614

object_name: Stage III Liver Cancer


subject: CHEBI:231614

object_name: Stage IIIA Adult Liver Cancer AJCC v7


subject: CHEBI:231614

object_name: Stage III Adult Liver Cancer AJCC v7


subject: CHEBI:231614

object_name: Stage IV Liver Cancer


subject: CHEBI:231614

object_name: Stage IV Adult Liver Cancer AJCC v7


subject: CHEBI:231614

object_name: Hepatic cancer stage IVA


subject: CHEBI:231614

object_name: Stage IVB Liver Cancer


subject: CHEBI:231614

object_name: Advanced Lung Carcinoma


subject: CHEBI:231614

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: unspecified childhood solid tumor, protocol specific


subject: GTOPDB:5962

subject_name: dovitinib

object_name: Solid Neoplasm


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:61057

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:61057

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:9296

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:9296

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:9296

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:9296

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:9296

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:9296

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:9296

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:9296

object_name: recurrent childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:9296

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:9296

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:9296

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:9296

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:9296

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:9296

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C4080033

object_name: Huntington disease


subject: PUBCHEM.COMPOUND:108169

subject_name: Taxane

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:108169

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:108169

object_name: breast cancer


subject: UMLS:C0796419

subject_name: Taxanes


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: CHEBI:2549

subject_name: Albuterol

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:2549

object_name: amyotrophic lateral sclerosis


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Diminished ovarian reserve


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C4082795

subject_name: Depsipeptide Antineoplastic Antibiotic

object_name: neoplasm


subject: UMLS:C0796678

subject_name: Depsipeptides


subject: CHEBI:84363

object_name: acute coronary syndrome


subject: CHEBI:84363

object_name: Prediabetes


subject: CHEBI:84363

object_name: glucose intolerance


subject: CHEBI:84363

object_name: Impaired glucose tolerance


subject: CHEBI:84363

object_name: coronary artery disorder


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: CHEBI:29235

object_name: Ischemic stroke


subject: CHEBI:18276

subject_name: Hydrogen


subject: UMLS:C0885426

subject_name: Hydrogen, Homeopathic preparation


subject: CHEMBL.COMPOUND:CHEMBL4297766

subject_name: HYDROGEN


subject: CHEBI:16433

subject_name: caffeic acid

object_name: autoimmune thrombocytopenia


subject: CHEBI:16433

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:16433

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:17395

subject_name: cis-caffeic acid


subject: CHEBI:17395


subject: CHEBI:17395


subject: DRUGBANK:DB17514

subject_name: Inobrodib

object_name: Plasma cell myeloma refractory


subject: DRUGBANK:DB17514

object_name: Relapse multiple myeloma


subject: DRUGBANK:DB17514

object_name: Plasma cell myeloma recurrent


subject: UNII:BW5QA5GEW7


subject: UNII:BW5QA5GEW7


subject: UNII:BW5QA5GEW7


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: HIV infection


subject: CHEBI:74332

subject_name: Leu-Asp

object_name: Parkinson disease


subject: PR:000007569


subject: UMLS:C2981846

object_name: Stomach cancer


subject: UMLS:C2981846

object_name: gastric cancer


subject: UMLS:C0003289

subject_name: Antidepressive Agents

object_name: dysthymic disorder


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: chronic hepatitis B virus infection


subject: CHEBI:91397

object_name: hepatitis B


subject: CHEBI:91397

object_name: follicular lymphoma


subject: CHEBI:66903

subject_name: Vismodegib

object_name: ovarian cancer


subject: CHEBI:66903

object_name: ovarian neoplasm


subject: CHEBI:66903

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Sensory hearing loss


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:231614

subject_name: Nivolumab

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:231614

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C3896863

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Stress


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:80271

subject_name: Glp-2 [MI]

object_name: short bowel syndrome


subject: UMLS:C0912332

subject_name: Glucagon-Like Peptide 2


subject: UMLS:C1174836

object_name: Neoplasm Metastasis


subject: UMLS:C1174836

object_name: breast neoplasm


subject: CHEBI:39112

subject_name: Bosutinib


subject: CHEBI:39112


subject: UNII:5IB2J79MCX

subject_name: Spesolimab

object_name: psoriasis 14, pustular


subject: UNII:5IB2J79MCX

object_name: pustulosis palmaris et plantaris


subject: CHEBI:91397

object_name: Mantle cell lymphoma stage I


subject: CHEBI:91397

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:91397

object_name: Mantle cell lymphoma stage III


subject: CHEBI:91397

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:91397

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: bladder tumor


subject: CHEBI:63791

object_name: urinary bladder carcinoma


subject: CHEBI:63791

object_name: urinary bladder cancer


subject: CHEBI:63791

object_name: childhood bladder carcinoma


subject: UNII:B19S3L3B7M

object_name: atopic eczema


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Advanced Neuroendocrine Carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:135512673

object_name: plasma cell myeloma


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: UMLS:C5238987

object_name: Small cell lung cancer limited stage


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UMLS:C4329337


subject: CHEBI:95043

object_name: Childhood Breast Carcinoma


subject: CHEBI:95043

object_name: breast carcinoma


subject: CHEBI:95043

object_name: breast cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ganglioneuroma


subject: UNII:2S9ZZM9Q9V

object_name: gangliocytoma


subject: UNII:2S9ZZM9Q9V

object_name: ganglioglioma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988

object_name: glioma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:49140

object_name: HER2 positive breast carcinoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: delayed function of renal transplant


subject: CHEBI:8081

subject_name: Phentolamine

object_name: Soft Tissue Injuries


subject: CHEBI:91400

subject_name: Afatinib

object_name: Adenocarcinoma of lung, stage III


subject: CHEBI:91400

object_name: EGFR gene mutation


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297747

subject_name: ENDOSTATIN


subject: UMLS:C0534628


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: osteoarthritis, knee


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: PUBCHEM.COMPOUND:9838675

subject_name: ARTEMISININ

object_name: Coronavinae infectious disease


subject: MESH:D037621

subject_name: Artemisinins


subject: CHEBI:63918

subject_name: Artesunate


subject: CHEBI:33322

subject_name: Rubidium

object_name: coronary artery disorder


subject: CHEBI:33322

object_name: coronary atherosclerosis


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Intubation complication


subject: CHEBI:33569

object_name: Anaesthesia intubation complication


subject: CHEBI:33569

object_name: hypotension and shock


subject: CHEBI:33569

object_name: respiratory failure


subject: CHEBI:33569

object_name: Respiratory Failure, CTCAE


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:9445

subject_name: Terazosin

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:9445

object_name: amyotrophic lateral sclerosis


subject: UNII:349552KRHK

subject_name: Simendan

object_name: aortic valve disease 2


subject: UNII:349552KRHK

object_name: aortic stenosis


subject: UNII:349552KRHK

object_name: aortic valve disease 3


subject: UNII:349552KRHK

object_name: Stenosis of aorta


subject: UNII:349552KRHK

object_name: Safety Issues


subject: UNII:349552KRHK

object_name: Cardiac Events


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:50567


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: Brain Thrombosis


subject: UNII:WGD229O42W

object_name: Drug action (disorder)


subject: UMLS:C3896864

subject_name: PSMA-targeted Tubulysin B-containing Conjugate EC1169

object_name: prostate carcinoma


subject: UMLS:C3896864

object_name: prostate cancer


subject: UMLS:C0695112

subject_name: Botulinum antitoxin, equine, any route

object_name: botulism


subject: UMLS:C0695112

object_name: Poisoning caused by Clostridium botulinum toxin


subject: UMLS:C0695112


subject: UMLS:C0695112


subject: MESH:D001904

subject_name: Botulinum Antitoxin


subject: MESH:D001904


subject: MESH:D001904


subject: MESH:D001904


subject: CHEBI:167473

subject_name: hexopyranose

object_name: Drug Resistant Epilepsy


subject: CHEBI:167473

object_name: SLC35A2-congenital disorder of glycosylation


subject: CHEBI:27667

subject_name: b-D-GALACTOSE


subject: CHEBI:27667


subject: CHEBI:28061

subject_name: galactose


subject: CHEBI:28061


subject: CHEBI:12936

subject_name: D-galactose


subject: CHEBI:12936


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: gingivitis


subject: PUBCHEM.COMPOUND:6912

object_name: Dental Plaque


subject: PUBCHEM.COMPOUND:6912

object_name: Saliva altered


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Coronavinae infectious disease


subject: CHEBI:15891

subject_name: Taurine

object_name: type 2 diabetes mellitus


subject: CHEBI:15891

object_name: Diabetes


subject: CHEBI:15891

object_name: diabetes mellitus


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: triple-negative breast carcinoma


subject: UMLS:C0013227

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Maternity blues


subject: PUBCHEM.COMPOUND:53477758

object_name: anxiety


subject: PUBCHEM.COMPOUND:53477758

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:53477758

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:53477758

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: PUBCHEM.COMPOUND:157088853

subject_name: Reamberin

object_name: diabetic ketoacidosis


subject: UMLS:C5555006

object_name: liver carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: central retinal vein occlusion


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: osteoarthritis, knee


subject: CHEBI:31186

object_name: age


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:156287

subject_name: Pidnarulex

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:16452

subject_name: Oxalacetate

object_name: Alzheimer disease


subject: MESH:D010071

subject_name: Oxaloacetates


subject: CHEBI:30744

subject_name: OXALOACETATE


subject: CHEBI:132560

subject_name: oligo(amidoamine)


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: Osteopenia


subject: UMLS:C5785434

subject_name: Microbiome-derived Peptide Vaccine EO4010

object_name: metastatic colorectal cancer


subject: UMLS:C5448936

subject_name: Tart Cherry

object_name: Myalgia


subject: CHEBI:6942

subject_name: Minoxidil

object_name: alopecia areata


subject: CHEBI:6942

object_name: alopecia


subject: PUBCHEM.COMPOUND:2791

subject_name: Clobetasol propionate


subject: PUBCHEM.COMPOUND:2791


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:205919


subject: PUBCHEM.COMPOUND:3734

subject_name: Iopamidol

object_name: Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: chronic hepatitis C virus infection


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: neuromyelitis optica


subject: CHEBI:50729

object_name: CNS demyelinating autoimmune disease


subject: CHEBI:50729

object_name: transverse myelitis


subject: CHEBI:50729

object_name: acute transverse myelitis


subject: CHEBI:50729

object_name: autoimmune disorder of the nervous system


subject: GTOPDB:8414

subject_name: trebananib

object_name: Adult Central Nervous System Neoplasm


subject: GTOPDB:8414

object_name: Childhood Central Nervous System Neoplasm


subject: GTOPDB:8414

object_name: central nervous system neoplasm


subject: GTOPDB:8414

object_name: central nervous system cancer


subject: GTOPDB:8414

object_name: Malignant neoplasm of the central nervous system


subject: GTOPDB:8414

object_name: Solid Neoplasm


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UMLS:C1541521

subject_name: AMG 386


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: complication following peripheral nerve block


subject: UMLS:C3864383

subject_name: Lumason

object_name: trauma to the abdomen


subject: GTOPDB:8086

subject_name: bimagrumab

object_name: Overweight or obesity


subject: CHEMBL.COMPOUND:CHEMBL3137353

subject_name: BIMAGRUMAB


subject: UMLS:C3896893


subject: CHEBI:167574

subject_name: Semaglutide


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: esophageal squamous cell carcinoma


subject: CHEBI:31607

subject_name: Ferrous fumarate

object_name: inflammatory bowel disease


subject: CHEBI:2659

subject_name: Aminophylline

object_name: pulmonary edema of mountaineers, susceptibility to


subject: CHEBI:135949

subject_name: Ambrisentan


subject: CHEBI:31401

subject_name: Cilostazol

object_name: vascular dementia


subject: CHEBI:5130

subject_name: Flurbiprofen

object_name: Bone injury


subject: CHEBI:5130

object_name: Bone Resorption


subject: CHEBI:5130

object_name: Stress Fracture


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: neoplastic meningitis


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UNII:3DGD69C6PV

subject_name: brigatinib

object_name: ALK-positive anaplastic large cell lymphoma


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: acute myeloid leukemia by FAB classification


subject: UNII:Y6BX7BL23K

object_name: acute myeloid leukemia


subject: UMLS:C5787294

object_name: glioblastoma


subject: UMLS:C5787294

object_name: Brain Stem Glioblastoma


subject: UMLS:C5787294

object_name: glioma susceptibility 1


subject: UMLS:C5787294

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C5787294

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C5787294

object_name: anaplastic astrocytoma


subject: UMLS:C5787294

object_name: malignant glioma


subject: UMLS:C5787294

object_name: High grade glioma


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: PUBCHEM.COMPOUND:57320831

subject_name: Urodilatin

object_name: heart failure


subject: PUBCHEM.COMPOUND:57320831

object_name: congestive heart failure


subject: GTOPDB:8446

subject_name: ularitide


subject: GTOPDB:8446


subject: UMLS:C0077910

subject_name: Ularitide


subject: UMLS:C0077910


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: ovarian cancer


subject: CHEBI:79699

object_name: ovarian neoplasm


subject: CHEBI:79699

object_name: ovarian carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Metastatic gastric adenocarcinoma


subject: UNII:5S371K6132

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: UMLS:C4547969


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C2729286

subject_name: Injection, docetaxel, 1 mg administered


subject: UMLS:C2729286


subject: UMLS:C5203163

subject_name: Docetaxel Liquid Injection


subject: UMLS:C5203163


subject: MESH:C079198

subject_name: S 1 (combination)


subject: MESH:C079198


subject: UMLS:C3180887

object_name: sleep disorder, initiating and maintaining sleep


subject: UMLS:C3180887

object_name: insomnia


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic Colorectal Carcinoma


subject: UNII:28X28X9OKV

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C0677986

subject_name: Peptide 946 Melanoma Vaccine

object_name: skin melanoma


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Recurrent ovarian cancer


subject: UNII:P0GVQ9A4S5

object_name: primary peritoneal carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Primary Peritoneal Cancer


subject: UNII:P0GVQ9A4S5

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: UMLS:C1958613

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1958613

object_name: obesity


subject: UMLS:C1958613

object_name: Obesity, CTCAE


subject: UMLS:C3272416

subject_name: PSMA-targeted Docetaxel Nanoparticles BIND-014

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C3272416

object_name: Embolism, Tumor


subject: UMLS:C3272416

object_name: Neoplasm Metastasis


subject: UMLS:C3272416

object_name: cancer


subject: UMLS:C3272416

object_name: neoplasm


subject: UMLS:C3272416

object_name: Solid Neoplasm


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:90936

subject_name: Alectinib

object_name: Advanced cancer


subject: CHEBI:90936


subject: CHEBI:90936

object_name: Childhood Solid Neoplasm


subject: CHEBI:90936

object_name: Adult Solid Neoplasm


subject: UNII:4T36H88UA7

subject_name: Apalutamide


subject: UNII:4T36H88UA7


subject: UNII:4T36H88UA7


subject: UNII:4T36H88UA7


subject: UNII:4T36H88UA7


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75045


subject: CHEBI:75045


subject: CHEBI:75045


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:195558

subject_name: Entrectinib


subject: CHEBI:195558


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib


subject: UNII:Y6BX7BL23K


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: UNII:1IJV77EI07

subject_name: Tepotinib


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: CHEBI:66903


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Subdural hemorrhage


subject: PUBCHEM.COMPOUND:22976653

object_name: fibrinolytic; hemorrhage


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: CHEBI:8988

object_name: diarrhea


subject: CHEBI:8988

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:8988

object_name: Diarrhea, CTCAE


subject: CHEBI:8988

object_name: childhood neoplasm


subject: CHEBI:8988

object_name: neoplastic syndrome


subject: CHEBI:8988

object_name: cancer or benign tumor


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:3504

subject_name: Cefpodoxime


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: UMLS:C5959681

subject_name: Lutetium Lu 177 XT117

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:18248

subject_name: Iron

object_name: malnutrition


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: PR:000017033

object_name: periodontitis, chronic, adult


subject: PR:000017033

object_name: chronic periodontitis


subject: UMLS:C0074512

subject_name: Signal Recognition Particle


subject: UMLS:C0074512


subject: UMLS:C4310002

object_name: kidney failure


subject: UMLS:C4310001


subject: CHEBI:9168

subject_name: Sirolimus

object_name: skin neoplasm


subject: UMLS:C5417836

object_name: rheumatoid arthritis


subject: UMLS:C5706385

subject_name: EGFR Inhibitor ERAS-801

object_name: Brain Stem Glioblastoma


subject: UMLS:C5706385

object_name: glioma susceptibility 1


subject: UNII:B68F5P9PB7


subject: UNII:B68F5P9PB7


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021

object_name: CD274 Gene Mutation


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C4076214

subject_name: Isopropyl methylphenol

object_name: gingivitis


subject: GTOPDB:12989

subject_name: toripalimab

object_name: salivary gland cancer


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: carotid atherosclerosis


subject: CHEBI:39548

object_name: Stroke (heart beat)


subject: CHEBI:39548

object_name: Stroke, CTCAE


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801

object_name: stroke disorder


subject: CHEBI:6801

object_name: cerebrovascular disorder


subject: CHEBI:6801


subject: CHEBI:6801


subject: CHEBI:34967

subject_name: Rimonabant


subject: CHEBI:34967

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:34967

object_name: metabolic syndrome X


subject: CHEBI:34967


subject: CHEBI:34967


subject: CHEBI:34967


subject: CHEBI:34967


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: myelofibrosis


subject: UMLS:C3641690


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Weight Gain


subject: CHEBI:36005

object_name: Weight Gain, CTCAE


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28364

subject_name: Icosapent

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:28364

object_name: obesity


subject: CHEBI:28364

object_name: Obesity, CTCAE


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEBI:92157

subject_name: octadeca-9,12-dienoic acid


subject: CHEBI:92157


subject: CHEBI:92157


subject: CHEBI:92157


subject: CHEBI:92157


subject: CHEBI:75108

subject_name: linoelaidic acid


subject: CHEBI:75108


subject: CHEBI:75108


subject: CHEBI:75108


subject: CHEBI:75108


subject: CHEBI:17351

subject_name: Linoleic acid


subject: CHEBI:17351


subject: CHEBI:17351


subject: CHEBI:17351


subject: CHEBI:17351


subject: PUBCHEM.COMPOUND:71462571

object_name: asthma


subject: UNII:07ODS257BP


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: preeclampsia


subject: PUBCHEM.COMPOUND:18541918

subject_name: Ampicillin-sulbactam

object_name: cholelithiasis


subject: CHEBI:51770

subject_name: Sultamicillin


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: UMLS:C0038135

subject_name: Standard Preparations

object_name: Vaccine adverse reaction


subject: PUBCHEM.COMPOUND:57404290

subject_name: Lanabecestat

object_name: Alzheimer disease


subject: UNII:X8SPJ492VF


subject: GTOPDB:5962

subject_name: dovitinib

object_name: Childhood Breast Carcinoma


subject: GTOPDB:5962

object_name: breast carcinoma


subject: GTOPDB:5962

object_name: breast cancer


subject: UNII:5Y27P3LNU6

subject_name: ETAKAFUSP ALFA

object_name: Childhood Solid Neoplasm


subject: UNII:5Y27P3LNU6

object_name: Adult Solid Neoplasm


subject: UNII:5Y27P3LNU6

object_name: Solid Neoplasm


subject: UNII:5Y27P3LNU6

object_name: head and neck squamous cell carcinoma


subject: UNII:5Y27P3LNU6

object_name: non-small cell lung carcinoma


subject: UNII:5Y27P3LNU6

object_name: nonpapillary renal cell carcinoma


subject: UNII:5Y27P3LNU6

object_name: clear cell renal carcinoma


subject: UNII:5Y27P3LNU6

object_name: renal cell adenocarcinoma


subject: UNII:5Y27P3LNU6

object_name: renal cell carcinoma


subject: UNII:5Y27P3LNU6

object_name: melanoma


subject: UMLS:C5785412

subject_name: Etakafusp Alfa


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: UMLS:C5785412


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: alcohol abuse


subject: CHEBI:6367

object_name: alcohol dependence


subject: CHEBI:6367

object_name: psychosis


subject: CHEBI:6367

object_name: Nonorganic psychosis


subject: CHEBI:6367

object_name: Psychosis, CTCAE


subject: CHEBI:6367

object_name: Mania, CTCAE


subject: CHEBI:6367

object_name: Mania


subject: CHEBI:93772

subject_name: Ispinesib

object_name: ovarian cancer


subject: CHEBI:93772

object_name: ovarian neoplasm


subject: CHEBI:93772

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:66624888

subject_name: Remodulin

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:66624888

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:66624888

object_name: pulmonary arterial hypertension


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Refractory shock


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:135905

subject_name: Terlipressin


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: skin melanoma


subject: UMLS:C4053601


subject: UMLS:C5907953

subject_name: Anti-LILRB2 Monoclonal Antibody OR502

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5907953

object_name: cancer


subject: UMLS:C5907953

object_name: neoplasm


subject: UMLS:C5907953

object_name: Childhood Solid Neoplasm


subject: UMLS:C5907953

object_name: Adult Solid Neoplasm


subject: UMLS:C5907953

object_name: Solid Neoplasm


subject: UMLS:C5907953

object_name: Primary malignant neoplasm


subject: UMLS:C5907953

object_name: childhood malignant neoplasm


subject: UMLS:C5907953

object_name: Malignant obstetric neoplasm


subject: UMLS:C5907953

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5907953

object_name: Embolism, Tumor


subject: UMLS:C5907953

object_name: Neoplasm Metastasis


subject: UMLS:C5907953

object_name: non-small cell lung carcinoma


subject: UMLS:C5907953

object_name: melanoma


subject: UMLS:C5907953


subject: PR:000029614

subject_name: putative RNA-binding protein Luc7-like 1

object_name: Metastatic malignant neoplasm to bone


subject: PR:000029614

object_name: Follicular neoplasm of thyroid


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: graft versus host disease


subject: UMLS:C0665297

subject_name: natalizumab


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: juvenile idiopathic arthritis


subject: UMLS:C0378942


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C4033631

subject_name: sacubitril / valsartan


subject: CHEBI:76607

subject_name: Macitentan

object_name: Pulmonary arterial hypertension associated with portal hypertension


subject: UMLS:C4683552

object_name: Neck Carcinoma


subject: UMLS:C4683552

object_name: head and neck neoplasm


subject: UMLS:C4683552

object_name: head and neck cancer


subject: CHEBI:31348

subject_name: Capecitabine

object_name: nasopharyngeal neoplasm


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Infant, Premature, Diseases


subject: CHEBI:80165

object_name: type 2 diabetes mellitus


subject: UMLS:C0726406

subject_name: Glycolic Acid 70%

object_name: Acne scar


subject: UMLS:C1330606

subject_name: Wellbutrin XL

object_name: mood disorder


subject: CHEBI:73275

subject_name: Ospemifene

object_name: Vaginal Dryness, CTCAE 5.0


subject: CHEBI:73275

object_name: Vaginal Dryness, CTCAE 3.0


subject: CHEBI:73275

object_name: Vaginal dryness


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: B-cell lymphoma refractory


subject: UNII:U2I8T43Y7R

object_name: B-cell lymphoma recurrent


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: prostate carcinoma


subject: CHEBI:64312

subject_name: Memantine

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:5931

subject_name: insulin human

object_name: Postprandial hyperglycemia


subject: UMLS:C0123677

subject_name: NovoLog


subject: UNII:I284LJY110

subject_name: Radotinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:91594

object_name: Adult Penile Carcinoma


subject: CHEBI:91594

object_name: penis carcinoma


subject: CHEBI:91594

object_name: penile cancer


subject: UMLS:C0678133

subject_name: Taxol


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: CHEBI:231222

subject_name: Cebranopadol

object_name: chronic pain (diagnosis)


subject: CHEBI:231222

object_name: Chronic pain


subject: CHEBI:231222

object_name: neoplasm


subject: UNII:7GDW9S3GN3


subject: UNII:7GDW9S3GN3


subject: UNII:7GDW9S3GN3


subject: UMLS:C3827125


subject: UMLS:C3827125


subject: UMLS:C3827125


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor


subject: UMLS:C0003015


subject: UMLS:C5907909

subject_name: Engineered Toxin Body Targeting CTLA-4 MT-8421

object_name: cervical cancer


subject: UMLS:C5907909

object_name: cervical carcinoma


subject: UMLS:C5907909

object_name: non-small cell lung carcinoma


subject: UMLS:C5907909


subject: UMLS:C5907909

object_name: microsatellite instability high


subject: UMLS:C5907909

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5907909

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5907909

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5907909

object_name: clear cell renal carcinoma


subject: UMLS:C5907909

object_name: renal cell adenocarcinoma


subject: UMLS:C5907909

object_name: renal cell carcinoma


subject: UMLS:C5907909

object_name: mismatch repair cancer syndrome 1


subject: UMLS:C5907909

object_name: Turcot syndrome


subject: UMLS:C5907909

object_name: Mismatch Repair Deficiency


subject: UMLS:C5907909

object_name: liver carcinoma


subject: UMLS:C5907909

object_name: urothelial carcinoma


subject: UMLS:C5907909

object_name: transitional cell carcinoma


subject: UMLS:C5907909

object_name: Mesothelioma


subject: UMLS:C5907909

object_name: mesothelial neoplasm


subject: UMLS:C5907909

object_name: malignant mesothelioma


subject: UMLS:C5907909

object_name: melanoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: cervical cancer


subject: CHEBI:231614

object_name: cervical carcinoma


subject: CHEBI:231614


subject: CHEBI:231614

object_name: microsatellite instability high


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: MESH:C000616902

subject_name: Gene-Eden-VIR

object_name: cytomegalovirus infection


subject: MESH:C000616902

object_name: EBV Infection


subject: MESH:C000616902

object_name: varicella zoster infection


subject: MESH:C000616902

object_name: herpes simplex


subject: MESH:C000616902

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: UMLS:C4506270


subject: UMLS:C4506270


subject: UMLS:C4506270


subject: UMLS:C4506270


subject: UMLS:C4506270


subject: HMDB:HMDB0253501

subject_name: Insulin degludec

object_name: cystic fibrosis


subject: HMDB:HMDB0253501

object_name: Prediabetes


subject: HMDB:HMDB0253501

object_name: glucose intolerance


subject: HMDB:HMDB0253501

object_name: Impaired glucose tolerance


subject: UMLS:C0123677


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: allergic asthma


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: Ischemic stroke


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: CHEBI:48720

subject_name: argatroban


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:11422859

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:10650

subject_name: Sumatriptan

object_name: Post-Traumatic Headache


subject: CHEBI:7476

subject_name: Naproxen


subject: RXCUI:1656349

subject_name: sacubitril 49 MG / valsartan 51 MG Oral Tablet

object_name: hypertension


subject: RXCUI:1656349

object_name: Hypertension, CTCAE


subject: RXCUI:1656349

object_name: cardiovascular disorder


subject: RXCUI:1656349

object_name: obesity due to melanocortin 4 receptor deficiency


subject: RXCUI:1656349

object_name: obesity


subject: RXCUI:1656349

object_name: Obesity, CTCAE


subject: UMLS:C5544321

object_name: Pneumonia caused by SARS-CoV-2


subject: PR:000017019

subject_name: UBX domain-containing protein 11


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:2704

object_name: Her2-receptor negative breast cancer


subject: CHEBI:2704

object_name: malignant neoplasm of breast stage I


subject: CHEBI:2704

object_name: Carcinoma breast stage I


subject: CHEBI:2704

object_name: Breast cancer stage II


subject: CHEBI:2704

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:2704

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:2704

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:2704

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:132082

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:49140

object_name: colorectal cancer


subject: CHEBI:49140

object_name: colorectal carcinoma


subject: CHEBI:49140

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:49140

object_name: lung cancer


subject: CHEBI:49140

object_name: lung carcinoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: UMLS:C4549686

object_name: chronic kidney disease


subject: UMLS:C4549686

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4549686

object_name: type 2 diabetes mellitus


subject: UNII:GNWE7KJ995

subject_name: Sutimlimab

object_name: cold agglutinin disease


subject: UNII:GNWE7KJ995

object_name: autoimmune hemolytic anemia, cold type


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: CHEBI:66964

subject_name: Dronabinol

object_name: cancer


subject: CHEBI:66964

object_name: neoplasm


subject: CHEBI:66964

object_name: Taste Disorders


subject: CHEBI:66964

object_name: Anorexia


subject: CHEBI:66964

object_name: Anorexia, CTCAE


subject: CHEBI:66964

object_name: Anorexia symptom


subject: CHEBI:66964

object_name: Disorder of olfactory system


subject: UNII:306QR91I9R

subject_name: Pelabresib

object_name: myelofibrosis


subject: UNII:306QR91I9R

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:306QR91I9R


subject: CHEBI:189653

subject_name: pelabresib


subject: CHEBI:189653


subject: CHEBI:189653


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:63605

object_name: Progesterone Receptor Positive


subject: CHEBI:63605

object_name: Progesterone Receptor Negative


subject: CHEBI:63605

object_name: Estrogen Receptor Negative


subject: CHEBI:63605

object_name: Estrogen Receptor Positive


subject: CHEBI:63605

object_name: HER2 positive


subject: CHEBI:63605

object_name: HER2/Neu Negative


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: MESH:C520255

object_name: Breast cancer recurrent


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:94683

subject_name: Cilomilast

object_name: COPD, severe early onset


subject: CHEBI:94683

object_name: chronic obstructive pulmonary disease


subject: UNII:8ATB1C1R6X


subject: UNII:8ATB1C1R6X


subject: CHEBI:30021

subject_name: Selenomethionine

object_name: lung cancer


subject: CHEBI:30021

object_name: lung neoplasm


subject: CHEBI:30021

object_name: lung carcinoma


subject: MESH:C000610984

subject_name: co-ultraPEALut


subject: MESH:C000610984

object_name: Hyposmia


subject: MESH:C000610984

object_name: Parosmia


subject: MESH:C000610984

object_name: anosmia


subject: MESH:C000610984

object_name: Anosmia, CTCAE


subject: PUBCHEM.COMPOUND:135483998

object_name: hypertension


subject: PUBCHEM.COMPOUND:135483998

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:135402010


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:20612


subject: CHEBI:20612


subject: CHEBI:15641

subject_name: 5-methyltetrahydrofolic acid


subject: CHEBI:15641


subject: PUBCHEM.COMPOUND:78092786

subject_name: Etelcalcetide

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:78092786

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C3712398


subject: UMLS:C3712398


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IB pancreatic cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IIA pancreatic cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Pancreatic carcinoma stage III


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IIB pancreatic cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: pancreatic adenocarcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:145499

subject_name: Donepezil

object_name: amblyopia


subject: UMLS:C0613070

subject_name: Calcium alpha-Ketoglutarate

object_name: eye disorder


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Does swallow


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:131174

subject_name: Navitoclax

object_name: triple-negative breast carcinoma


subject: CHEBI:131174

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:131174

object_name: ovarian cancer


subject: CHEBI:131174

object_name: ovarian neoplasm


subject: CHEBI:131174

object_name: ovarian carcinoma


subject: CHEBI:131174

object_name: High grade serous carcinoma


subject: CHEBI:4445

subject_name: Desflurane

object_name: delirium


subject: CHEBI:4445

object_name: Delirium, CTCAE


subject: CHEBI:4445

object_name: Postoperative cognitive dysfunction


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: outcomes general quality of life


subject: UNII:2S9ZZM9Q9V

object_name: Perceived quality of life


subject: UNII:2S9ZZM9Q9V

object_name: Good quality of life


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: keloid


subject: UMLS:C2934702

object_name: Chronic small plaque psoriasis


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: portal hypertension


subject: UMLS:C4721945

object_name: Portal Hypertension, CTCAE


subject: DRUGBANK:DB18378

object_name: eosinophilic esophagitis


subject: DRUGBANK:DB18378

object_name: Eosinophilic infiltration of the esophagus


subject: DRUGBANK:DB18378

object_name: celiac disease


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3852764

object_name: non-Hodgkin lymphoma


subject: UMLS:C1271481

subject_name: Recombinant human granulocyte colony stimulating factor


subject: UMLS:C1271481


subject: UMLS:C0376562

subject_name: Recombinant Granulocyte Colony Stimulating Factor


subject: UMLS:C0376562


subject: UNII:I284LJY110

subject_name: Radotinib

object_name: leukemia


subject: UNII:I284LJY110

object_name: childhood leukemia


subject: UNII:I284LJY110

object_name: Philadelphia Chromosome


subject: UNII:I284LJY110

object_name: myeloid leukemia


subject: UNII:I284LJY110

object_name: hematologic disorder


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:133021

object_name: myoclonic dystonia 11


subject: UMLS:C2346810

object_name: prostate carcinoma


subject: UMLS:C2346810

object_name: prostate cancer


subject: CHEBI:36796

subject_name: duloxetine

object_name: Solid Neoplasm


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB17107

object_name: suppressor of tumorigenicity 3


subject: DRUGBANK:DB17107

object_name: cervical carcinoma


subject: CHEBI:23704

subject_name: diepoxybutane

object_name: liver carcinoma


subject: UMLS:C4085979

object_name: extranodal nasal NK/T cell lymphoma


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Philadelphia Chromosome Negative


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UNII:PVI5M0M1GW

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: GTOPDB:13890

subject_name: quavonlimab

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:GG0AN49Y59

subject_name: QUAVONLIMAB


subject: UMLS:C4725918

subject_name: Quavonlimab


subject: UMLS:C5706457

subject_name: Anti-CD39 Antibody/TGF-beta RII Ectodomain Fusion Protein ES014

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Amputated structure (morphologic abnormality)


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:9168

object_name: Refractory Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C5400059

object_name: acute lymphoblastic leukemia


subject: UMLS:C5400059

object_name: acute myeloid leukemia


subject: UMLS:C0039341

subject_name: tat Protein

object_name: HIV infection


subject: CHEBI:6801

subject_name: Metformin

object_name: acanthosis nigricans


subject: CHEBI:6801

object_name: familial acanthosis nigricans


subject: CHEBI:6801

object_name: hyperinsulinism


subject: CHEBI:6801

object_name: Hyperinsulinemia


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Malignant Solid Neoplasm


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: CHEBI:85164


subject: CHEBI:5523

subject_name: Goserelin

object_name: Kennedy disease


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: rheumatoid arthritis


subject: UMLS:C0665297

subject_name: natalizumab


subject: UNII:O874Z20U79

object_name: retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome


subject: MESH:C558471

subject_name: Hizentra

object_name: plasma cell myeloma


subject: MESH:C558471

object_name: Plasma cell tumor, malignant


subject: MESH:C558471

object_name: plasma cell neoplasm


subject: UMLS:C3494178

subject_name: Intravenous Immunoglobulins, Human


subject: UMLS:C3494178


subject: UMLS:C3494178


subject: UMLS:C0086333

subject_name: Gammagard


subject: UMLS:C0086333


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: CHEBI:10033

subject_name: Warfarin

object_name: Acute bacterial skin and skin structure infection


subject: UMLS:C3827078

subject_name: DNA Minor Groove Binding Agent SG2000

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3827078

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3827078


subject: UNII:2LHZ9ZC3YO

subject_name: Tolinapant

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Head and Neck Carcinoma of Unknown Primary


subject: UNII:2LHZ9ZC3YO

object_name: Locally Advanced Laryngeal Squamous Cell Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Locally Advanced Hypopharyngeal Squamous Cell Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Locally Advanced Oropharyngeal Squamous Cell Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Locally Advanced Nasopharyngeal Squamous Cell Carcinoma


subject: CHEBI:231324

subject_name: alpelisib

object_name: Childhood Solid Neoplasm


subject: CHEBI:231324

object_name: Adult Solid Neoplasm


subject: CHEBI:231324

object_name: Solid Neoplasm


subject: CHEBI:231324

object_name: Stomach cancer


subject: CHEBI:231324

object_name: gastric cancer


subject: CHEBI:5931

subject_name: insulin human

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0876064

subject_name: Lantus


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: chronic hepatitis B virus infection


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: CHEBI:28741

subject_name: Sodium fluoride

object_name: Dental Plaque


subject: CHEBI:28741

object_name: gingivitis


subject: PUBCHEM.COMPOUND:20734893

subject_name: Fluticasone furoate

object_name: Hay fever


subject: CHEBI:94366

subject_name: itraconazole

object_name: bacterial infectious disease


subject: CHEBI:63631

subject_name: Topiramate

object_name: cocaine use disorder


subject: CHEBI:8499

subject_name: Propranolol

object_name: asthma


subject: UMLS:C0732195

subject_name: Qvar 50


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Metastatic hepatocellular carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:305790

subject_name: thyroxine

object_name: abortion


subject: CHEBI:305790

object_name: Pregnancy loss


subject: CHEBI:305790

object_name: Pregnancy Loss, CTCAE


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: UMLS:C3536952

subject_name: Central Nervous System Stimulant [EPC]

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C3536952


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: UMLS:C3714648

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: UMLS:C3714648

object_name: Poisoning by anticoagulant


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: CHEBI:28384


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: CHEBI:18067


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: UMLS:C2936884


subject: UMLS:C3541386

subject_name: Estrogens, endocrine therapy drugs

object_name: osteoporosis


subject: UMLS:C3537250

subject_name: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: CHEBI:50114

subject_name: estrogen


subject: UMLS:C3714615

subject_name: Estrogens Drug Class


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Androgen excess


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Phantom Limb Pain


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: Hepatobiliary cancer


subject: UNII:45X7OU8C4J

object_name: liver cancer


subject: UNII:45X7OU8C4J

object_name: liver neoplasm


subject: UNII:45X7OU8C4J

object_name: Adult Liver Carcinoma


subject: UNII:45X7OU8C4J

object_name: liver carcinoma


subject: UNII:45X7OU8C4J

object_name: cholangiocarcinoma


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UNII:14J2G0U3NQ

subject_name: Laromustine

object_name: leukemia


subject: UNII:14J2G0U3NQ

object_name: childhood leukemia


subject: UNII:14J2G0U3NQ


subject: UMLS:C1568660

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C1568660

object_name: non-Hodgkin lymphoma


subject: UMLS:C1568660

object_name: neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: nasal cavity and paranasal sinus carcinoma


subject: UNII:DPT0O3T46P

object_name: laryngeal carcinoma


subject: UNII:DPT0O3T46P

object_name: larynx cancer


subject: UNII:DPT0O3T46P

object_name: oral cavity carcinoma


subject: UNII:DPT0O3T46P

object_name: oral cavity cancer


subject: UNII:DPT0O3T46P

object_name: oropharyngeal carcinoma


subject: UNII:DPT0O3T46P

object_name: oropharynx cancer


subject: UNII:DPT0O3T46P

object_name: hypopharynx cancer


subject: UNII:DPT0O3T46P

object_name: squamous cell carcinoma of lip


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: cutaneous squamous cell carcinoma


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J

object_name: malignant tumor of nasopharynx


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:84363

object_name: coronary atherosclerosis


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:32599

object_name: Idiopathic scoliosis and kyphoscoliosis


subject: CHEBI:32599

object_name: idiopathic scoliosis


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: CHEBI:3752

subject_name: Clomifene

object_name: hypogonadism, male


subject: CHEBI:50922

subject_name: Eletriptan

object_name: Migraine with or without aura


subject: CHEBI:28918

subject_name: Epinephrine

object_name: no feeling or sensation of skin


subject: PUBCHEM.COMPOUND:46174089

subject_name: GLUCOSAMINE SULFATE

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:46174089

object_name: osteoarthritis susceptibility 1


subject: CHEBI:28393

subject_name: D-glucosamine


subject: CHEBI:37878

subject_name: glucosamine sulfate


subject: CHEBI:37878


subject: CHEBI:20993

subject_name: GLUCOSAMINE


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: Axial Spondyloarthritis


subject: UMLS:C4310469

subject_name: Mencevax ACWY

object_name: meningococcal infection


subject: MESH:C068994

subject_name: cellodextrin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C068994

object_name: obesity


subject: MESH:C068994

object_name: Obesity, CTCAE


subject: UMLS:C2984015

object_name: bladder transitional cell carcinoma


subject: UMLS:C2984015

object_name: transitional cell carcinoma


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Hepatic cysts


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:91973920

object_name: prostate cancer


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: MESH:D056604


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: DRUGBANK:DB16606


subject: UMLS:C0733524

subject_name: Aracytine

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0733524

object_name: acute myeloid leukemia


subject: CHEBI:229658

subject_name: Perfluorohexyloctane

object_name: Dry Eye, CTCAE


subject: CHEBI:229658

object_name: Dryness of eye


subject: UNII:12M44VTJ7B

subject_name: DALTEPARIN SODIUM

object_name: pregnancy disorder


subject: UNII:12M44VTJ7B

object_name: Thrombophilia Related to COVID-19


subject: UNII:12M44VTJ7B

object_name: thrombophilia


subject: UNII:12M44VTJ7B

object_name: Pregnant


subject: UMLS:C0498888

subject_name: INJECTION, DALTEPARIN SODIUM, PER 2500 IU ADMINISTERED


subject: UMLS:C0498888


subject: UMLS:C0498888


subject: UMLS:C0498888


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: CHEBI:164200

subject_name: Triclosan

object_name: dentin sensitivity


subject: CHEBI:30563

subject_name: Silicon dioxide


subject: CHEBI:29228

subject_name: FLUORIDE


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Sepsis


subject: UMLS:C3714501

object_name: Sepsis, CTCAE


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Amputated structure (morphologic abnormality)


subject: UNII:8SSL98OST3

object_name: cancer


subject: UNII:8SSL98OST3

object_name: neoplasm


subject: UMLS:C5418005


subject: UMLS:C5418005


subject: UMLS:C5238383

subject_name: Zirconium Zr 89-DFO-SC16.56

object_name: small cell lung carcinoma


subject: UMLS:C4682889

subject_name: Selective Estrogen Receptor Degrader SAR439859

object_name: Childhood Breast Carcinoma


subject: UMLS:C4682889

object_name: breast carcinoma


subject: UMLS:C4682889

object_name: breast cancer


subject: CHEBI:229213

subject_name: Elacestrant

object_name: ductal breast carcinoma in situ


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:80555

subject_name: ENDOXIFEN


subject: UMLS:C0957573


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: diffuse cutaneous systemic sclerosis


subject: UNII:7XL5ISS668

object_name: diffuse scleroderma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C4763426

subject_name: Tuparstobart

object_name: endometrial cancer


subject: UMLS:C4763426

object_name: uterine corpus cancer


subject: UMLS:C4763426

object_name: endometrial carcinoma


subject: UMLS:C5206703

subject_name: INCAGN 02390


subject: UMLS:C5206703


subject: UMLS:C5206703


subject: GTOPDB:8221

subject_name: epacadostat


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UNII:2Y3T5IF01Z


subject: UNII:2Y3T5IF01Z


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:71013

subject_name: Perampanel

object_name: focal epilepsy


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: BRAF gene mutation


subject: CHEBI:75045

object_name: Hepatic Complication


subject: CHEBI:75045

object_name: kidney failure


subject: CHEBI:75045

object_name: Renal Failure, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: thrombotic thrombocytopenic purpura


subject: CHEBI:41879

object_name: Thrombotic Thrombocytopenic Purpura, CTCAE


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UNII:4HA45S22ZZ

object_name: lung cancer


subject: UNII:4HA45S22ZZ

object_name: lung neoplasm


subject: UNII:4HA45S22ZZ

object_name: lung carcinoma


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:2549

subject_name: Albuterol

object_name: Mild chronic obstructive pulmonary disease


subject: CHEBI:2549

object_name: Signs and Symptoms, Respiratory


subject: UMLS:C0772489

subject_name: Norepinephrine Hydrochloride

object_name: no feeling or sensation of skin


subject: UMLS:C0772489

object_name: Sensory Loss


subject: UMLS:C0772489

object_name: Blood Pressure Finding


subject: UMLS:C0772489

object_name: Systemic arterial pressure


subject: UMLS:C4283878

subject_name: Neutrophil Activation Probe Imaging Agent

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4283878

object_name: B-cell neoplasm


subject: PR:000010986

subject_name: napsin-A


subject: PR:000010986


subject: PR:000006011

subject_name: beta-catenin-like protein 1


subject: PR:000006011


subject: CHEBI:80566

subject_name: Palifosfamide

object_name: Small cell lung cancer extensive stage


subject: UMLS:C2987344

subject_name: palifosfamide-tris


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) refractory


subject: CHEBI:4026

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) refractory


subject: CHEBI:4026

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) recurrent


subject: CHEBI:4026

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Acute lymphoblastic leukemia, in relapse


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:133021

subject_name: Venetoclax


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: progression free survival


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Small cell lung cancer limited stage


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C0962969

subject_name: RAD 001

object_name: Stomach cancer


subject: UMLS:C0962969

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib

object_name: acute myeloid leukemia


subject: UNII:6EM57086EA


subject: UMLS:C5418040


subject: UMLS:C5418040


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000014196


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: cystic fibrosis


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Microsatellite Stable Colorectal Carcinoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: UMLS:C2703099

object_name: Advanced Melanoma


subject: UNII:54534MX6Z9

subject_name: Teclistamab

object_name: Relapse multiple myeloma


subject: UMLS:C4527013


subject: CHEBI:8707

subject_name: Quetiapine

object_name: insomnia


subject: CHEBI:8707

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:8707

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:8707

object_name: mental disorder


subject: CHEBI:9654

subject_name: Trazodone


subject: CHEBI:9654

object_name: Substance Use Disorders


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: Chronic small plaque psoriasis


subject: UNII:11Z5AIU653

subject_name: simtuzumab

object_name: sclerosing cholangitis


subject: CHEMBL.COMPOUND:CHEMBL2109667

subject_name: SIMTUZUMAB


subject: UMLS:C2984523


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Age-Related Memory Disorders


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908

object_name: mood disorder


subject: CHEBI:94265

subject_name: Cerubidin

object_name: non-Hodgkin lymphoma


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:32660

subject_name: asparaginase


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Postoperative Complications


subject: CHEBI:81916

subject_name: Pancrelipase


subject: UNII:FQ3DRG0N5K


subject: UMLS:C0111046

subject_name: Creon


subject: UMLS:C1302030

subject_name: amylase / lipase / protease


subject: UNII:74Q3U8O789

subject_name: Fluoroacetic acid F-18

object_name: prostate carcinoma


subject: UNII:74Q3U8O789

object_name: prostate cancer


subject: UNII:74Q3U8O789

object_name: brain cancer


subject: UNII:74Q3U8O789

object_name: brain neoplasm


subject: UNII:74Q3U8O789

object_name: Childhood Breast Carcinoma


subject: UNII:74Q3U8O789

object_name: breast carcinoma


subject: UNII:74Q3U8O789

object_name: breast cancer


subject: UMLS:C5139956


subject: UMLS:C5139956


subject: UMLS:C5139956


subject: UMLS:C5139956


subject: UMLS:C5139956


subject: UMLS:C5139956


subject: UMLS:C5139956


subject: CHEBI:77733

subject_name: Verapamil

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:77733

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:77733

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:77733

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:77733

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:53188

subject_name: verapamil hydrochloride


subject: CHEBI:53188


subject: CHEBI:53188


subject: CHEBI:53188


subject: CHEBI:53188


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: castration-resistant prostate carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: Metastatic malignant neoplasm to bone


subject: UNII:QEN1X95CIX

object_name: prostate adenocarcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Chronic low back pain


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Arrested active phase of labor


subject: CHEBI:74705

object_name: Labor (Obstetrics)--Complications


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: papillary craniopharyngioma


subject: PUBCHEM.COMPOUND:51038893

object_name: BRAF V600E Mutation Present


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:64073

object_name: myocardial infarction


subject: CHEBI:64073

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:64073

object_name: Myocardial Infarction by ECG Finding


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:71226663

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:71226663

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:71226663

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: UMLS:C3272413

subject_name: STAT3 Inhibitor OPB-51602

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3272413

object_name: acute lymphoblastic leukemia


subject: UMLS:C3272413

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3272413

object_name: acute myeloid leukemia


subject: UMLS:C3272413

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3272413

object_name: non-Hodgkin lymphoma


subject: UMLS:C3272413

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C3272413

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3272413

object_name: plasma cell myeloma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: anemia


subject: CHEBI:201431

object_name: Anemia, CTCAE


subject: CHEBI:201431

object_name: Lymphocytosis


subject: CHEBI:201431

object_name: T-cell leukemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: GTOPDB:11346

subject_name: vilobelimab

object_name: skin squamous cell carcinoma


subject: UNII:F5T0RF9ZJA


subject: UMLS:C5392705


subject: UMLS:C4759828

object_name: prostate neoplasm


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: systemic sclerosis


subject: MESH:C000619755

object_name: diffuse cutaneous systemic sclerosis


subject: MESH:C000619755

object_name: diffuse scleroderma


subject: MESH:C000619755


subject: CHEBI:177833

subject_name: Cilengitide

object_name: small intestine cancer


subject: CHEBI:177833

object_name: small intestine carcinoma


subject: CHEBI:177833

object_name: myeloproliferative neoplasm


subject: CHEBI:177833

object_name: Myelodysplasia


subject: CHEBI:177833

object_name: leukemia


subject: CHEBI:177833

object_name: childhood leukemia


subject: CHEBI:177833

object_name: adult lymphoma


subject: CHEBI:177833

object_name: lymphoma


subject: CHEBI:177833

object_name: pediatric lymphoma


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C5556779

subject_name: COX-2 Inhibitor ECP-1014

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556779

object_name: Adult Solid Neoplasm


subject: UMLS:C5556779

object_name: Solid Neoplasm


subject: CHEBI:3423

subject_name: Carmustine

object_name: acute graft versus host disease


subject: CHEBI:3423

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:41264

subject_name: butyl group


subject: CHEBI:41264


subject: CHEBI:41264


subject: CHEBI:41264

object_name: hematologic disorder


subject: CHEBI:41264


subject: CHEBI:41264

object_name: non-Hodgkin lymphoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:6456

subject_name: Lidocaine

object_name: progressive familial heart block, type 1A


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: hepatitis C


subject: CHEBI:49040

object_name: chronic hepatitis C virus infection


subject: UMLS:C2985197

object_name: Richter syndrome


subject: CHEBI:9168

subject_name: Sirolimus

object_name: scleritis


subject: CHEBI:4471

subject_name: dextromethorphan hydrobromide

object_name: Cough


subject: CHEBI:4471

object_name: Cough, CTCAE


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146178


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: UMLS:C2985200

object_name: pancreatic neoplasm


subject: UMLS:C2985200

object_name: gastric neoplasm


subject: UMLS:C5854539

subject_name: Anti-PD-L1/4-1BB Bispecific Antibody QLF31907

object_name: Advanced cancer


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: Psoriasis of scalp


subject: CHEBI:114785

subject_name: Erlotinib

object_name: brain cancer


subject: CHEBI:114785

object_name: childhood brain stem glioma


subject: CHEBI:114785

object_name: brain stem glioma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage IV Lung Cancer AJCC v7